News» Go to news main
Congratulations to Dr. Susan Ripley for receiving a COVID‑19 Innovation Grant. Six initiatives are receiving a total of $1 million in funding to support their COVID‑19 innovation.
N95 masks remain one of the most effective ways of protecting front-line workers from COVID-19. As a result, they are in very high demand. For an N95 mask to be 95% effective, it must fit tightly to the face. Without a tight seal, air flows around the perimeter of the mask, rendering it ineffective and increasing the risk of COVID-19 infection. This tight seal makes N95s extremely uncomfortable to wear for long periods of time, even causing damage to health care workers’ faces.
Dr. Susan Ripley and the Takaya Technology Inc. team have designed an N95 mask that creates an effective and tight-fitting seal, yet is comfortable enough to wear for an entire shift. Their goal is to make sure all health care workers have sufficient access to effective, comfortable masks. A world-leading supplier has already expressed interest in collaboration or licensing their design and are in discussions with provincial and federal governments to raise awareness of their innovation.
About the recipient
Dr. Susan Ripley, BSc, MSc, CCFP, is the Chief Medical Officer for Takaya Technology Inc and the Halifax Site Director for the Department of Family Medicine at Dalhousie University. She is an acute medicine hospitalist and has done research across varied disciplines including basic science, neurosurgical, biomedical and patient safety and quality improvement initiatives.
- Dr. Helena Piccinini Appointed Research Director
- Dr. Sarah Cook Appointed Chief, IWK Department of Family Medicine – Maternal Newborn Care
- Register for the 2022 Faculty Development Workshop
- The Nova‑Scotia portion of the PriCARE Program leadership has been taken over by Dr. Joanna Zed
- Congratulations to the ACTing Collectively Project Team
- Dr. Emily Gard Marshall featured on Women Now TV
- Happy International Women's Day
- Dalhousie Family Medicine faculty Dr. Ruth Lavergne named Tier 2 Canada Research Chair in Primary Care